These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11133700)

  • 1. Anticipation for enzymatic vitreolysis.
    Bhisitkul RB
    Br J Ophthalmol; 2001 Jan; 85(1):1-2. PubMed ID: 11133700
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological vitrectomy.
    Tanaka M; Qui H
    Semin Ophthalmol; 2000 Mar; 15(1):51-61. PubMed ID: 10749315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is pharmacologic vitreolysis brewing?
    Sebag J
    Retina; 2002 Feb; 22(1):1-3. PubMed ID: 11884870
    [No Abstract]   [Full Text] [Related]  

  • 4. Microplasmin for vitreomacular traction.
    Udaondo P; Diaz-Llopis M; Garcia-Delpech S; Salom D; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1859, 1859.e1; author reply 1859-60. PubMed ID: 20816250
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathology of Internal Limiting Membrane Specimens Following Intravitreal Injection of Ocriplasmin.
    Schumann RG; Wolf A; Mayer WJ; Compera D; Hagenau F; Ziada J; Kampik A; Haritoglou C
    Am J Ophthalmol; 2015 Oct; 160(4):767-78. PubMed ID: 26133247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological vitreolysis].
    Gandorfer A
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute ocriplasmin retinopathy.
    Johnson MW; Fahim AT; Rao RC
    Retina; 2015 Jun; 35(6):1055-8. PubMed ID: 25996428
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in vitreoretinal surgery--time to stop and think.
    Leaver PK
    Br J Ophthalmol; 1999 Apr; 83(4):385-6. PubMed ID: 10434855
    [No Abstract]   [Full Text] [Related]  

  • 9. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.
    de Smet MD; Gandorfer A; Stalmans P; Veckeneer M; Feron E; Pakola S; Kampik A
    Ophthalmology; 2009 Jul; 116(7):1349-55, 1355.e1-2. PubMed ID: 19447497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe art thou?
    Kim JE
    JAMA Ophthalmol; 2014 Apr; 132(4):379-80. PubMed ID: 24577332
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel possibility of vitreomacular traction treatment.
    Michalska-Małecka K; Witek K; Sierocka-Stępień J; Wyględowska-Promieńska D; Nowak M
    Acta Ophthalmol; 2016 Dec; 94(8):e818-e819. PubMed ID: 27167161
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the adverse effects of ocriplasmin.
    Beebe DC
    JAMA Ophthalmol; 2015 Feb; 133(2):229. PubMed ID: 25376025
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the adverse effects of ocriplasmin - reply.
    Johnson MW; Fahim AT
    JAMA Ophthalmol; 2015 Feb; 133(2):230. PubMed ID: 25375273
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of enzymatic vitreolysis on the absorption of experimental vitreous hemorrhage. Preliminary report].
    Zagórski Z
    Klin Oczna; 1983 May; 85(5):197-9. PubMed ID: 6316024
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic Vitreolysis in Vascular Diseases of the Retina.
    Soliman MK; Agarwal A; Sarwar S; Hanout M; Sadiq MA; Do DV; Nguyen QD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):60-8. PubMed ID: 26731211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?
    Johnson MW
    Am J Ophthalmol; 2013 Feb; 155(2):203-205.e1. PubMed ID: 23312439
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic vitreolysis.
    Sebag J
    Retina; 1998; 18(1):1-3. PubMed ID: 9502274
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture.
    Machemer R
    Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1771-83. PubMed ID: 3056866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progression of pharmacologic vitreolysis research].
    Zhou H; Ye J
    Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.